Sonia Quaratino
Chief Medical Officer
Kymab
United Kingdom
Biography
Dr Quaratino has over 20 years' experience in clinical development and immunology research. Sonia joined Kymab from Novartis, where she served as Global Clinical Program Leader - Transitional Clinical Oncology, responsible for the clinical development of proprietary therapeutic antibody programmes in immuno-oncology. Prior to her role with Novartis, Dr Quaratino was Senior Medical Director and Immunology Advisor at Merck Serono, where she was responsible for the clinical development of various immunomodulators.
Research Interest
Dr Quaratino has over 20 years' experience in clinical development and immunology research.
